2型糖尿病的病因:一段实验医学的探索之旅
本文综述了为验证「双循环假说」而开展的长期研究,该假说认为2型糖尿病由脂肪诱导的肝脏和胰腺功能障碍所致。Counterpoint研究支持该假说,DiRECT随机对照研究显示12个月内β细胞功能几乎恢复正常,进一步3年随访中严重不良事件发生率较标准治疗对照组减半。在BMI 21-27 kg/m2的2型糖尿病患者中逐步减重可使70%获得缓解,个人脂肪阈值差异较大。
要点
- 双循环假说认为2型糖尿病由脂肪诱导的肝、胰功能障碍所致,减重可能使病情逆转。
- DiRECT研究显示12个月内β细胞功能几乎恢复正常,3年随访严重不良事件较对照组减半。
- BMI 21-27 kg/m2的2型糖尿病患者逐步减重后70%获得缓解,脂肪阈值差异大。
核心结论
- 2型糖尿病可被视为遗传异质性个体中病因同质的一种疾病。
- 双循环假说和个人脂肪阈值假说均预测2型糖尿病可通过减重逆转。
研究设计与样本
- 本综述描述了一项长期实验医学研究,旨在检验双循环假说和个人脂肪阈值假说。
- 研究包括Counterpoint研究、DiRECT 2年随机对照研究及后续3年常规护理随访。
主要发现
- Counterpoint研究结果支持双循环假说,后续研究确定短病程糖尿病在减重10-15 kg后更可能缓解,且等热量正常饮食下缓解可持续6个月。
- 减重仅使2型糖尿病患者的胰腺脂肪立即减少,减重手术后餐后肠促胰素峰值与空腹血糖正常化无关。
- DiRECT研究显示12个月内β细胞功能几乎恢复正常,小部分参与者体重反弹后2型糖尿病复发,其病理生理机制与双循环假说预测一致。
- 进一步3年常规护理随访显示严重不良事件发生率较标准治疗对照组减半。
- BMI 21-27 kg/m2的2型糖尿病患者逐步减重后70%获得缓解,脂肪阈值范围较宽。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This review describes a prolonged research endeavour to test the twin cycle hypothesis that type 2 diabetes is caused by fat-induced dysfunction of the liver and pancreas, guided by the happenstance of clinical practice. Testing of the personal fat threshold hypothesis, that individuals exhibit different levels of tolerance to intra-organ fat accumulation, is also described. Both hypotheses predict that type 2 diabetes is potentially reversible by weight loss. The results of the Counterpoint study supported the twin cycle hypothesis, leading to a second study which determined that short-duration diabetes was more likely to remit following the 10-15 kg weight loss. It also confirmed that remission was durable over 6 months on an isoenergetic, normal diet. Subsequently, it was shown that weight loss caused an immediate decrease of pancreas fat only in people with type 2 diabetes and also that postprandial incretin spikes after bariatric surgery had no role in normalising fasting plasma glucose. DiRECT, a 2 year randomised controlled study, demonstrated clinical utility, observing functional beta cell capacity to return almost to normal over 12 months. A small group of participants regained weight and redeveloped type 2 diabetes, allowing observation that the underlying pathophysiological mechanisms during onset of diabetes were as postulated by the twin cycle hypothesis. Major clinical benefit was demonstrated after a further 3 year follow-up in routine care, halving the incidence of serious adverse effect compared with the standard treatment control group. In answer to the question of whether individuals have a personal fat threshold for tolerance of fat, stepwise weight loss in people with type 2 diabetes and BMI in the range 21-27 kg/m2 resulted in remission in 70%, with a wide range of fat thresholds. Type 2 diabetes can be regarded as a condition of homogenous aetiology in genetically heterogenous individuals.
引用
- Taylor R. Aetiology of type 2 diabetes: an experimental medicine odyssey. Diabetologia. 2025. PMID: 40316731. doi:10.1007/s00125-025-06428-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。